Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study Article

Prados, MD, Yung, WKA, Jaeckle, KA et al. (2004). Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study . NEURO-ONCOLOGY, 6(1), 44-54. 10.1215/S1152851703000292

Open Access

cited authors

  • Prados, MD; Yung, WKA; Jaeckle, KA; Robins, HI; Mehta, MP; Fine, HA; Wen, PY; Cloughesy, TF; Chang, SM; Nicholas, MK; Schiff, D; Greenberg, HS; Junck, L; Fink, KL; Hess, KR; Kuhn, J

sustainable development goals

authors

publication date

  • January 1, 2004

webpage

published in

keywords

  • ACTIVE METABOLITE
  • ADULTS
  • Clinical Neurology
  • EXPRESSION
  • GLUCURONIDATION
  • HUMAN LIVER
  • INHIBITOR
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • RESISTANCE
  • SN-38
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 44

end page

  • 54

volume

  • 6

issue

  • 1